Detalles de la búsqueda
1.
Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial.
Gastrointest Endosc
; 93(1): 174-182.e2, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32464142
2.
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA).
Ann Rheum Dis
; 74(5): 818-22, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24448345
3.
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial.
Lancet Gastroenterol Hepatol
; 8(1): 43-55, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240801
4.
Dual targeting of lymphocyte homing and retention through α4ß7 and αEß7 inhibition in inflammatory bowel disease.
Cell Rep Med
; 2(8): 100381, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34467254
5.
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program.
Adv Ther
; 37(7): 3417-3431, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445184
Resultados
1 -
5
de 5
1
Próxima >
>>